Microfluidic Immuno-Biochip for Detection of Breast Cancer Biomarkers Using Hierarchical Composite of Porous Graphene and Titanium Dioxide Nanofibers
- 3 August 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 8 (32), 20570-20582
- https://doi.org/10.1021/acsami.6b05648
Abstract
We report on a label-free microfluidic immunosensor with femtomolar sensitivity and high selectivity for early detection of epidermal growth factor receptor 2 (EGFR2 or ErbB2) proteins. This sensor utilizes a uniquely structured immunoelectrode made of porous hierarchical graphene foam (GF) modified with electrospun carbon-doped titanium dioxide nanofibers (nTiO2) as an electrochemical working electrode. Due to excellent biocompatibility, intrinsic surface defects, high reaction kinetics, and good stability for proteins, anatase nTiO2 are ideal for electrochemical sensor applications. The three-dimensional and porous features of GF allow nTiO2 to penetrate and attach to the surface of the GF by physical adsorption. Combining GF with functional nTiO2 yields high charge transfer resistance, large surface area, and porous access to the sensing surface by the analyte, resulting in new possibilities for the development of electrochemical immunosensors. Here, the enabling of EDC-NHS chemistry covalently immobilized the antibody of ErbB2 (anti-ErbB2) on the GF-nTiO2 composite. To obtain a compact sensor architecture, the composite working electrode was designed to hang above the gold counter electrode in a microfluidic channel. The sensor underwent differential pulse voltammetry and electrochemical impedance spectroscopy to quantify breast cancer biomarkers. The two methods had high sensitivities of 0.585 μA μM(-1) cm(-2) and 43.7 kΩ μM(-1) cm(-2) in a wide concentration range of target ErbB2 antigen from 1 × 10(-15) M (1.0 fM) to 0.1 × 10(-6) M (0.1 μM) and from 1 × 10(-13) M (0.1 pM) to 0.1 × 10(-6) M (0.1 μM), respectively. Utilization of the specific recognition element, i.e., anti-ErbB2, results in high specificity, even in the presence of identical members of the EGFR family of receptor tyrosine kinases, such as ErbB3 and ErbB4. Many promising applications in the field of electrochemical detection of chemical and biological species will derive from the integration of the porous GF-nTiO2 composite into microfluidic devices.Funding Information
- Division of Biological Infrastructure (DBI-1353819)
- Division of Electrical, Communications and Cyber Systems (ECCS-1102354)
- Plant Sciences Institute, Iowa State University
This publication has 57 references indexed in Scilit:
- Anti-epidermal growth factor receptor conjugated mesoporous zinc oxide nanofibers for breast cancer diagnosticsNanoscale, 2015
- The ErbB/HER family of protein-tyrosine kinases and cancerPharmacological Research, 2014
- Paper-based microfluidic point-of-care diagnostic devicesLab on a Chip, 2013
- Electrochemical immunosensor with N-doped graphene-modified electrode for label-free detection of the breast cancer biomarker CA 15-3Biosensors and Bioelectronics, 2012
- Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensorSensors and Actuators B: Chemical, 2010
- Biosensors for cancer markers diagnosisSeminars in Cell & Developmental Biology, 2009
- Electrochemical biosensors: Towards point-of-care cancer diagnosticsBiosensors and Bioelectronics, 2006
- Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growthCancer Cell, 2002
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- Validation of immunoassays for bioanalysis: a pharmaceutical industry perspectiveJournal of Pharmaceutical and Biomedical Analysis, 1999